Inovio Pharmaceuticals, Inc. (INO) NASDAQ
1.13
-0.61(-35.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.13
-0.61(-35.06%)
Currency In USD
| Market Cap | 815.82M |
| Enterprise Value | 780.92M |
| P/E Ratio | -6.24 |
| PEG Ratio | -0.22 |
| Price/Sales Ratio | 926.75 |
| Price/Book Ratio | 21.99 |
| Enterprise/Revenue | 392.56 |
| Enterprise/EBITDA | -0.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1,300 |
| Operating Margin | -1,328.71 |
| Return On Assets | -1.14 |
| Return On Equity | -3.53 |
| Revenue | 65,343 |
| Revenue/Share | 0 |
| Gross Profit | 65,343 |
| EBITDA | -81.96M |
| Net Income | -84.95M |
| Diluted EPS | -1.81 |
| Total Cash | 58.51M |
| Total Cash/Share | 0.12 |
| Total Debt | 9.37M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1.4 |
| Book Value Per Share | 0.05 |
| 52-Week Change | -28.93 |
| 52-Week High | 2.98 |
| 52-Week Low | 1.07 |
| Moving Average 50 Days | 1.66 |
| Moving Average 200 Days | 1.93 |
| Average Volume | 1.07M |
| Shares Outstanding | 53.59M |
| % Held by Institutions | 63.31 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | January 25, 2024 |